Breaking News

Over a week ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Syndicate
NanoVibronix files $35M mixed securities shelf  06:30
07/21/20
07/21
06:30
07/21/20
06:30
NAOV

NanoVibronix

$1.78 /

-0.01 (-0.56%)

 
ShowHide Related Items >><<
NAOV NanoVibronix
$1.78 /

-0.01 (-0.56%)

Over a month ago
Hot Stocks
NanoVibronix signs two-year exclusive pact with with Ultra Pain Products » 08:10
07/07/20
07/07
08:10
07/07/20
08:10
NAOV

NanoVibronix

$2.20 /

+0.25 (+12.82%)

NanoVibronix announced…

NanoVibronix announced that effective June 22, it has entered into a two-year exclusive agreement with Ultra Pain Products for the distribution of NanoVibronix's proprietary PainShield devices and components through and by Durable Medical Equipment Distributors throughout the United States. Under the terms of the two-year agreement, the company granted exclusive distribution rights to UPPI to sell the newest model of PainShield MD and components, including the new ergonomic design and single-use custom daily dressing or adhesive through DME distributors. In exchange, the company received an initial purchase order and minimum annual quantities, which must be achieved. The agreement is subject to minimum unit pricing restrictions and bi-monthly order quantity minimums in the first year that increase and shift to quarterly order minimums in year two. Distribution rights expressly exclude sales to Veteran's Facilities under the Federal Supply Schedule.

ShowHide Related Items >><<
NAOV NanoVibronix
$2.20 /

+0.25 (+12.82%)

Hot Stocks
NanoVibronix expands license agreement with Ideal Medical International » 08:04
06/01/20
06/01
08:04
06/01/20
08:04
NAOV

NanoVibronix

$2.28 /

-0.1 (-4.20%)

NanoVibronix announced…

NanoVibronix announced that it has expanded its license agreement with Ideal Medical International Limited to include exclusive rights to distribute the company's UroShield and PainShield technologies in Canada and Turkey effective May 27. Under the terms of the 10 year, performance-based agreement, the company will receive an upfront license fee, payable immediately, and quarterly royalty payments based on a sliding scale of Ideal Medical's gross sales of the company's licensed technologies with minimum performance milestones beginning in year two of the agreement, and shall absorb costs associated with relevant regulatory approvals for Ideal Medical to market, distribute and sell the company's licensed technologies that are subject to the agreement.

ShowHide Related Items >><<
NAOV NanoVibronix
$2.28 /

-0.1 (-4.20%)

Over a quarter ago
Hot Stocks
NanoVibronix signs license agreement with Sanuwave Health for WoundShield » 08:05
04/02/20
04/02
08:05
04/02/20
08:05
NAOV

NanoVibronix

$2.09 /

-0.08 (-3.69%)

, SNWV

Sanuwave Health

$0.00 /

+ (+0.00%)

NanoVibronix (NAOV)…

NanoVibronix (NAOV) signed a license agreement with Sanuwave Health (SNWV) for the manufacture and delivery of its WoundShield technology. NanoVibronix will receive 100,000 warrants of Sanuwave stock, a $250K milestone payment based on FDA approval, and 10% royalty on Sanuwave's gross revenues from sales or rentals of WoundShield. In return, Sanuwave has received the worldwide, exclusive rights to the company's WoundShield product and technology. In addition, Sanuwave will bear the costs and clinical validation responsibilities associated with obtaining approval for WoundShield from the FDA and other regulatory agencies around the world. WoundShield is a therapeutic ultrasound system that is intended to accelerate wound healing by increasing blood flow and oxygenation of tissue.

Hot Stocks
NanoVibronix receives reimbursement approval from CMS for PainShield » 08:14
04/01/20
04/01
08:14
04/01/20
08:14
NAOV

NanoVibronix

$2.17 /

-0.18 (-7.66%)

NanoVibronix announced…

NanoVibronix announced that the U.S. Centers for Medicare and Medicaid Services has approved its PainShield for reimbursement for Medicare beneficiaries on a national basis effective January 2020. The company was notified on March 30, 2020 that its Medicare Enrollment Application was approved, and it is now an approved Medicare Supplier for DME through the National Supplier Clearinghouse, Palmetto-GBA as well as Noridian Administrative Services, LLC, the two Medicare Administrative Contractors that handle DME reimbursement nationwide. PainShield is now available for Medicare reimbursement on a national level under new HCPCS code K1004. PainShield is an ultrasound device, consisting of a reusable driver unit and a disposable patch, which contains a proprietary therapeutic transducer.

Hot Stocks
NanoVibronix provides business update for Q3 » 08:31
11/19/19
11/19
08:31
11/19/19
08:31
NAOV

NanoVibronix

$3.05 /

+0.05 (+1.67%)

NanoVibronix provided a…

NanoVibronix provided a business update for Q3. "This has been a productive and important quarter for NanoVibronix, positioning us for accelerating growth in 2020 and beyond," commented Brian Murphy, CEO of NanoVibronix. "In the past few quarters, we have significantly expanded our manufacturing capabilities, growing capacity from approximately 100 per month to, initially, over 1,000 per month with the ability to grow. Simultaneously, we have broadened our distribution channels, adding key partners to directly target key potential customers, including the Federal Supply Schedule and CMS/Medicare, and we are making progress in our efforts to target the Veterans Administration and European customers through private label arrangements. We believe that we have the optimal team in place to deliver. We enter the Q4 in the best strategic position in our company's history, and I am excited about the opportunities in front of us. Our new Chinese manufacturer has finished first products on November 15th, and should have 3,000 units completed by early January. Our current pipeline, including back orders, and fulfilling our first private label order, will consume the majority of our initial production. Our new licensing arrangement with Medisana is progressing as planned, and this manufacturing capability enables us to support Medisana's growth. Other potential partners are in various stages of discover, clinical testing, and market testing, which we feel very comfortable about."

ShowHide Related Items >><<
NAOV NanoVibronix
$3.05 /

+0.05 (+1.67%)

01/09/19 Dawson James
NanoVibronix initiated with a Buy at Dawson James
Hot Stocks
NanoVibronix: PainShield device receives unique reimbursement code from CMS » 08:10
11/18/19
11/18
08:10
11/18/19
08:10
NAOV

NanoVibronix

$3.00 /

+0.1 (+3.45%)

NanoVibronix announced…

NanoVibronix announced that the Centers for Medicare and Medicaid has assigned a unique, Level II product reimbursement code under the Healthcare Common Procedure Coding System for use in 2020. HCPCS code K1004 will help facilitate reimbursement for the use of PainShield.

ShowHide Related Items >><<
NAOV NanoVibronix
$3.00 /

+0.1 (+3.45%)

01/09/19 Dawson James
NanoVibronix initiated with a Buy at Dawson James
Hot Stocks
NanoVibronix awarded OEM purchase order by Medisana » 08:36
08/27/19
08/27
08:36
08/27/19
08:36
NAOV

NanoVibronix

$2.81 /

+ (+0.00%)

NanoVibronix announced…

NanoVibronix announced significant progress with a leading global consumer healthcare company, Medisana, which has resulted in an initial Original Equipment Manufacturing, or OEM, purchase order. The Company will commence the manufacture of a specialized product for Medisana based on its PainShield device called the PT-100. The product will be sold directly and exclusively via Medisana.

ShowHide Related Items >><<
NAOV NanoVibronix
$2.81 /

+ (+0.00%)

01/09/19 Dawson James
NanoVibronix initiated with a Buy at Dawson James

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.